DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Dovlatova NL, Jakubowski JA, Sugidachi A, Heptinstall S.
The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function.
J Thromb Haemost 2008;
6 (07) 1153-1159
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.